Image credit: Rexgenero The first UK clinical trial site for the treatment of diabetic patients with chronic limb-threatening ischaemia using a novel patient-specific regenerative therapy has opened for patient recruitment at the University Hospital of Wales in Cardiff. The site will be evaluating REX-001 (Rexgenero) in two phase III trials codenamed the [...]